Skip to content

The impact of combination thromboprophylaxis on patients with unexplained recurrent spontaneous abortions.

Evaluation of the efficacy of aspirin and low molecular weight heparin in patients with unexplained recurrent spontaneous abortions.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT138811073215N1
Enrollment
100
Registered
2010-05-26
Start date
2008-10-07
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pregnancy rate beyond 20 weeks of gestational age in habitual aborters. Pregnancy care of habitual abortor

Interventions

Low Molecular Weight Heparin, 5000 unit subcutaneous twice a day and Asprin 80 mg po daily till 36 weeks of pregnancy or any premature sign of preterm delivery.
Prevention
Low Molecular Weight Heparin, 5000 unit subcutaneous twice a day and Asprin 80 mg po daily till 36 weeks of pregnancy or any premature sign of preterm delivery

Sponsors

vice canceller for research of Shiraz University of Medical Siences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: Incidence of at least 3 consecutive recurrent abortions Exclusion criteria: known cause of recurrent abortion, abnorml TFT, FBS, or FSH (3rd day of cycle), uterine anomaly, positive antiphospholipid Ab or anticardiolipin Ab, presence of thrombophilia, abnormal karyotype of both couples

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Continuation of pregnancy beyond 20 weeks of pregnancy. Timepoint: 20 weeks after last menstural period. Method of measurement: alive fetus by ob sonography or hearing fetal heart by sonocate or fetoscope.

Secondary

MeasureTime frame
Live birth rate. Timepoint: after delivery. Method of measurement: live fetus delivery after 28 weeks of gestational age.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Ahmadpour

Department of ob&gyn

ahmadpour@sums.ac.ir+98 71 1233 2365

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026